The FDA's decision to ban Red Dye No. 3 isn't the beginning of a transparency movement—it's part of a broader shift that's been reshaping the food industry for years. Consumers today are ...

The clear multistate E. coli outbreak linked to romaine lettuce raises concern about the FDA and transparency — the failure to disclose where consumers purchased the tainted product and who the ...

Functional and cross-functional teams expect greater data transparency to make compliance easier, which would mitigate the risk of drug supply gaps. Every day that a drug isn't available costs a ...

Emphasizing the central principles of transparency and bias control, as well as risk-based approaches, the FDA’s guidance underlines the importance of careful data management, documentation ...